Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Csl Ltd ADR (CSLLY)

Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases

The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks.

GSK : 34.03 (-0.09%)
CSLLY : 88.7500 (+1.09%)
SNY : 48.29 (-0.21%)
CSL Appoints Jeffrey Ball as First Chief Sustainability Officer

/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...

CSL : 376.45 (-0.02%)
CSLLY : 88.7500 (+1.09%)
Why CSL Ltd Stock Could Be Worth a Look

FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.

CSL : 376.45 (-0.02%)
CSLLY : 88.7500 (+1.09%)
NVS : 98.35 (-0.10%)
BLUE : 7.79 (+1.70%)
ARCT : 16.53 (+0.12%)
Why Arcturus Therapeutics Stock Is Skyrocketing Today

Investors are applauding Arcturus' collaboration with CSL.

CSL.AX : 280.750 (+0.95%)
CSLLY : 88.7500 (+1.09%)
ARCT : 16.53 (+0.12%)
Finalization of Vifor Pharma acquisition

Regulatory News:

CSL.AX : 280.750 (+0.95%)
OTC.VN : 0.300 (-9.09%)
CSLLY : 88.7500 (+1.09%)
uniQure announces closing of commercialization and license agreement with CSL Behring

Upfront payment of $450 million due to uniQure by May 13, 2021

CSLLY : 88.7500 (+1.09%)
ASX : 10.55 (+1.64%)
QURE : 17.35 (-0.46%)
The Latest: Mexico to lower virus alert level in many states

MEXICO CITY __ Mexico is reducing its COVID-19 alert level in about half of the country’s states amid a drop in infections and hospitalizations in many places, including the capital.

PFE : 26.74 (+0.11%)
CSL : 376.45 (-0.02%)
CSLLY : 88.7500 (+1.09%)
The Latest: Australia's 2nd largest city to begin lockdown

MELBOURNE, Australia — Australia’s second-largest city will begin its third lockdown due to a rapidly spreading COVID-19 cluster centered on hotel quarantine.

JNJ : 145.85 (+0.40%)
CSL : 376.45 (-0.02%)
CSLLY : 88.7500 (+1.09%)

Barchart Exclusives

Unusual Options Volume in Palantir Puts Could Signal a Stock Peak
A huge, unusual volume in Palantir Technologies put options may signal a near-term peak in PLTR stock. It has doubled since its Q3 earnings on Nov. 4. However, put premiums are now very high—an income play for short-sellers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar